ADMA Biologics, Inc. (ADMA)

NASDAQ

$13.21

$+2.82

(+26.91%)

Regular Market

ADMA Biologics, Inc. (ADMA) Live Price Chart

Last updated: ⁦2026-11-05 20:06:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

ADMA Biologics, Inc. (ADMA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $13.21, with a market capitalization of $2.49B and a P/E ratio of 14.73. Over the past 52 weeks, its price has ranged from $7.21 to $20.46. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.49B
Open	$12.01
Day's High	$25.67
Day's Low	$1.01
Previous Close	$10.48
Volume	12.07M
Average Volume	2.84M
P/E Ratio	14.73
52-Week High	$20.46
52-Week Low	$7.21
Dividend Yield	--
Earnings Date	--

ADMA Biologics, Inc. (ADMA) Stock Price Today

ADMA Biologics, Inc. (ADMA) is currently trading at $13.21 as of 2026-11-05 19:50:33, up 26.00% ($2.72) from the previous close of $10.48

During today's regular trading session, ADMA has traded between $1.01 and $25.67, with a trading volume of 12.07M shares. The current price is near the middle of today's range.

ADMA Biologics, Inc. (ADMA) 7-Day Stock Price Change

Over the past seven days, ADMA Biologics, Inc. (ADMA) moved from $11.17 to $13.21, representing a gain of 18.22% ($2.04).

The stock traded between $10.25 and $13.71 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 4.49 million shares, up versus the previous seven-day period, indicating higher trading activity.

ADMA 52-Week Price Position

Position in Range: 45.3%

52W Low$7.21

52W High$20.46

ADMA is currently trading at $13.21, placing it 45.3% of the way from its 52-week low of $7.21 to its 52-week high of $20.46. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is ADMA Biologics, Inc. (ADMA)?

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

ADMA Biologics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	647
Exchange	NASDAQ
Company Website	https://www.admabiologics.com

How to Buy ADMA Biologics, Inc. (ADMA) Stock on MEXC

Eligible investors can buy real shares of ADMA Biologics, Inc. (ADMA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ADMA and Place Your Order

Open the RealStocks trading page and search for ADMA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is ADMA Biologics, Inc. (ADMA) stock price today?

ADMA Biologics, Inc. (ADMA) is currently trading at $ 13.21, up 26.00% ($2.72) from the previous close of $ 10.48. Intraday prices update in real time during regular trading hours.

2.Is ADMA stock going up or down today?

As of 2026-11-05 19:50:33, ADMA is trading at $ 13.21, up 26.00% ($2.72) from its previous close of $ 10.48. The stock has traded between $ 1.01 and $ 25.67 during today’s regular session. Past price movements do not guarantee future results.

3.What is ADMA pre-market price?

As of 2026-11-05 19:50:33, ADMA is trading at $ 12.02 in pre-market trading, up 14.69% ($1.54) from the previous close of $ 10.48. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ADMA after-hours price?

As of 2026-11-05 19:50:33, ADMA is trading at $ 13.45 in after-hours trading, up 28.32% ($2.97) from the regular-session close of $ 10.48. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ADMA stock trading now?

ADMA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ADMA sit relative to its 52-week high and low?

Over the past 52 weeks, ADMA has traded between a low of $ 7.21 and a high of $ 20.46. At $ 13.21, the stock is positioned 45.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is ADMA Biologics, Inc. in?

ADMA Biologics, Inc. (ADMA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is ADMA Biologics, Inc.'s market capitalization and where is it listed?

ADMA Biologics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 2.49B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ADMA valued in terms of P/E ratio and EPS?

ADMA trades at a P/E ratio of 14.73, based on trailing-twelve-month EPS of $ 0.75. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does ADMA Biologics, Inc. pay a dividend?

ADMA Biologics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.